What top creators are saying about KSI-501(KSI-501)

Kodiak Sciences' investigational treatment for eye diseases

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about KSI-501 in the last 30 days yet.

Top creators covering KSI-501 (KSI-501)

The 2 sources with the most insights about KSI-501 on Kazuha.

Latest insights about KSI-501 (KSI-501)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, September 28, 2026

Neutral

Wet AMD results supported non-inferiority and statistical equivalence to aflibercept, despite numerically lower visual-acuity gain. Potential benefit in inflammatory subgroups, particularly DME, awaits further study.

Saturday, September 26, 2026

Very Bearish

The treatment was criticized for failing to demonstrate an advantage over Eylea while requiring more frequent injections; the speaker anticipated another failure.

Discussed alongside KSI-501 (KSI-501)

Other assets that creators frequently mention in the same content as KSI-501.

Frequently asked

Which podcasters and creators cover KSI-501 (KSI-501) the most?

The most active sources covering KSI-501 (KSI-501) on Kazuha are @realmartinshkreli, @shkreliplanet. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about KSI-501 (KSI-501) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about KSI-501 (KSI-501) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside KSI-501 (KSI-501)?

Creators covering KSI-501 (KSI-501) most frequently also discuss KOD, EYLEA, VABY, AVST, KSI-301. See the "Discussed alongside" section above for full asset pages.